<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurol Med Chir (Tokyo)</journal-id><journal-id journal-id-type="iso-abbrev">Neurol. Med. Chir. (Tokyo)</journal-id><journal-id journal-id-type="publisher-id">NMC</journal-id><journal-title-group><journal-title>Neurologia medico-chirurgica</journal-title></journal-title-group><issn pub-type="ppub">0470-8105</issn><issn pub-type="epub">1349-8029</issn><publisher><publisher-name>The Japan Neurosurgical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24077275</article-id><article-id pub-id-type="pmc">4508753</article-id><article-id pub-id-type="doi">10.2176/nmc.cr2012-0271</article-id><article-id pub-id-type="publisher-id">nmc-53-722</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Slow Progression of Calcified Cerebellar Metastasis From Ovarian Cancer: A Case Report and Review of the Literature</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kawamura</surname><given-names>Daichi</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Toshihide</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="C1"/></contrib><contrib contrib-type="author"><name><surname>Fuga</surname><given-names>Michiyasu</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yanagisawa</surname><given-names>Takeshi</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tochigi</surname><given-names>Satoru</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Irie</surname><given-names>Koreaki</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hasegawa</surname><given-names>Yuzuru</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abe</surname><given-names>Toshiaki</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><aff id="AFF1"><label>1</label>Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, Kashiwa, Chiba</aff></contrib-group><author-notes><corresp id="C1"><italic>Address reprint requests to:</italic> Toshihide Tanaka, MD, PhD, Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, 163-1 Kashiwa-shita, Kashiwa, Chiba 277-8567, Japan. <italic>e-mail</italic>: <email>ttanaka@jikei.ac.jp</email></corresp><fn fn-type="COI-statement"><p><bold>Conflicts of Interest Disclosure</bold></p><p>The authors have no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2013</year></pub-date><volume>53</volume><issue>10</issue><fpage>722</fpage><lpage>726</lpage><history><date date-type="received"><day>26</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>10</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>
&#x000a9; 2013 The Japan Neurosurgical Society
</copyright-statement><copyright-year>
2013
</copyright-year><license license-type="open-access"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit <ext-link xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p></license></permissions><abstract><p>The report describes a rare case of a patient with a calcified cerebellar metastasis arising from a primary ovarian cancer. The patient was a 33-year-old woman with a long history of stage IIIc ovarian cancer who had undergone transabdominal hysterectomy and bilateral oophorectomy followed by chemotherapy with gemcitabine hydrochloride. Incidentally, computed tomography (CT) revealed a cerebellar tumor with calcification. The size of the tumor gradually increased, and lateral suboccipital craniotomy was performed for gross total removal of the tumor. The histological diagnosis was ovarian mucinous adenocarcinoma. The patient's postoperative course was uneventful, and she was discharged two days after surgery. Brain metastases from ovarian cancer are rare. In the review of metastatic brain tumors arising from a primary ovarian cancer in the Department of Obstetrics and Gynecology at our institution, this phenomenon was noted in only 10 cases (0.24%) of 4,158 patients with ovarian cancer seen at our center over a period of 8 years. Moreover, only three cases of calcified metastatic brain tumor have been reported previously. In conclusion, complete tumor resection may be an acceptable approach for patients with calcified metastatic tumors both for therapeutic considerations and to obtain tissue for confirmation of histopathological diagnosis. Metastatic brain tumors can be calcified, and should be considered within the differential diagnosis of calcified intracranial lesions to avoid any delay in diagnosis or treatment.</p></abstract><kwd-group><kwd>calcified metastasis</kwd><kwd>cerebellar</kwd><kwd>ovarian cancer</kwd><kwd>surgery</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Intracranial calcified masses are usually associated with slowly progressive benign tumors (e.g., oligodendroglioma and meningioma), infectious diseases (e.g., tuberculosis, fungal infection, cysticercosis), and metabolic disorders (e.g., hyperparathyroidism).</p><p>Calcified metastases to the brain have been described in patients with squamous cell carcinoma of the lung,<sup><xref rid="B7" ref-type="bibr">7)</xref></sup> adenocarcinoma of the lung,<sup><xref rid="B3" ref-type="bibr">3)</xref></sup> sarcoma of the mediastinum,<sup><xref rid="B13" ref-type="bibr">13)</xref></sup> squamous cell carcinoma of the cervix,<sup><xref rid="B4" ref-type="bibr">4)</xref></sup> adenocarcinoma of the pancreas,<sup><xref rid="B1" ref-type="bibr">1)</xref></sup> and non-Hodgkin's lymphoma.<sup><xref rid="B16" ref-type="bibr">16)</xref></sup> Only four cases of calcified metastases to the brain arising from a primary ovarian carcinoma have been described.<sup><xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B11" ref-type="bibr">11)</xref></sup></p><p>Generally, calcified brain tumors in those cases remained stable and did not progress. In fact, these patients had relatively benign clinical courses and prolonged survival. All four cases were multiple lesions and the interval between diagnosis of ovarian cancer and brain metastases was 3&#x02013;12 months.</p><p>The present report describes a case of a patient with a single large cerebellar calcified metastatic tumor mimicking meningioma that arose from a primary ovarian cancer. This patient also had a relatively benign clinical courses and favorable survival, and the latent period was 10 years, which was longer than that in previous reported cases.</p></sec><sec><title>Case Report</title><p>A 33-year-old woman had a notable history of ovarian cancer diagnosed 10 years prior that was treated by surgical resection and adjuvant systemic chemotherapy. During a screening examination, a calcified cystic lesion was incidentally noted in the right cerebellar hemisphere on computed tomography (CT) (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). The patient declined any treatment for the presumed cerebellar tumor and instead elected for serial follow-up. The size of the tumor gradually increased, while she was asymptomatic (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Two years after the initial CT, she presented with headache and positional vertigo, and CT showed enlargement of the calcified tumor and hydrocephalus (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). Magnetic resonance imaging (MRI) showed a lesion that was isointense on T<sub>1</sub>-weighted images and heterogeneously hyperintense on the T<sub>2</sub>-weighted image with slight heterogeneous enhancement with gadolinium (<xref ref-type="fig" rid="F2">Fig. 2A&#x02013;C</xref>). Tonsillar herniation with obstructive hydrocephalus was also recognized (<xref ref-type="fig" rid="F2">Fig. 2D</xref>).</p><p>Informed consent was obtained, and right lateral suboccipital craniotomy was performed. The tumor was located subpially and appeared as a well-demarcated elastic hard mass that could be easily distinguished from the surrounding parenchyma. The tumor was gross totally removed. Histological findings revealed that the tumor cells were arranged in an acinar formation with psammomatous calcification in the stroma with atypical and mitotic tumor cells. The lesion was compatible with a diagnosis of serous mucinous adenocarcinoma (<xref ref-type="fig" rid="F3">Fig. 3</xref>). MIB-1 index was 3% (data not shown) (MIB-1: Mindbomb E3 ubiquitin protein ligase 1). Postoperatively, the patient experienced improvement in her symptoms of headache and vertigo, and her postoperative course was uneventful. Postoperative CT and MRI revealed that the tumor was gross totally removed and demonstrated marked improvement in the tonsillar herniation and obstructive hydrocephalus (<xref ref-type="fig" rid="F4">Figs. 4</xref>, <xref ref-type="fig" rid="F5">5</xref>). She got discharged two days after surgery. Subsequently, she received whole brain irradiation.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Calcification of metastatic brain tumors is very rare and tends to occur in the basal ganglia and cerebellum, which are rich in endogenous iron and calcium.<sup><xref rid="B9" ref-type="bibr">9)</xref></sup> At least two different mechanisms have been postulated to explain marked calcification of metastatic brain tumors.<sup><xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B12" ref-type="bibr">12)</xref></sup> First, reduced metabolism of degenerative or necrotic tissue can interrupt CO<sub>2</sub> production, making the lesions more alkaline than the surrounding tissues, thereby promoting calcification. Alternatively, calcification might be mediated by an increase in local alkaline phosphatase levels in degenerative tissues. In the presence of hypoxia, the equilibrium of extracellular calcium fails, resulting in an influx of calcium into the cell and subsequent calcium phosphate deposition. In a stable microenvironment, calcium phosphate may eventually be converted into calcium hydroxyapatite, and crystal proliferation can follow, with the extension of calcification into the extracellular space. Calcification, therefore, may follow cell death and may be promoted by the presence of alkaline phosphate.</p><p>Generally, the differential diagnosis between metastatic brain tumors and benign intracranial tumors, including meningioma and oligodendroglioma, is exceedingly important, especially for treatment planning.<sup><xref rid="B14" ref-type="bibr">14)</xref></sup> Calcified brain tumors are occasionally misdiagnosed in the absence of edema and contrast enhancement, resulting in a delay in diagnosis and/or treatment.<sup><xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B11" ref-type="bibr">11)</xref></sup></p><p>In the present case, a patient with stage IIIc ovarian cancer treated with surgery and chemotherapy developed cerebellar metastasis 10 years after the initial diagnosis of her cancer. The cerebellar tumor was incidentally discovered by CT and, at the patient's preference, was followed conservatively. Initially, the tumor was considered to be a benign tumor, possibly a meningioma. However, slow growth of the tumor ultimately resulted in headache and vertigo due to tonsillar herniation and obstructive hydrocephalus at 2 years after detection of the brain lesion. On this basis, emergent surgical management was elected.</p><p>A previous study<sup><xref rid="B17" ref-type="bibr">17)</xref></sup> using serial brain CT scans reported that size of the calcified metastatic brain tumors tended to increase at a rate slower than ordinary brain metastasis and can thereby be misinterpreted as meningioma.</p><p>Calcified brain tumors tend to remain quiescent without progression.<sup><xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B10" ref-type="bibr">10)</xref></sup> Considering the long periods of time required to develop calcium deposits, calcification appears more frequently in benign cysts or slow-growing tumors. On the other hand, loss of calcification indicates accelerated growth of malignant tumors.<sup><xref rid="B5" ref-type="bibr">5)</xref></sup> Calcified meta-static brain tumors are very rare, but are also clinically important, as a delay in diagnosis and treatment can adversely impact survival.</p><p>Cancers arising in the lungs, colon, and breast are the most frequently reported primary cancer types that result in calcified intracranial metastases, while brain metastasis from ovarian cancer is comparatively rare. In the review of metastatic brain tumors arising from a primary ovarian cancer in the Department of Obstetrics and Gynecology at our institution, this phenomenon was noted in only 10 cases (0.24%) of 4,158 patients with ovarian cancer seen at our center over a period of 8 years (<xref ref-type="table" rid="T1">Table 1</xref>). In addition, only four cases of calcified brain metastasis arising from ovarian cancer have been reported thus far<sup><xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B11" ref-type="bibr">11)</xref></sup> (<xref ref-type="table" rid="T2">Table 2</xref>). The interval between treatment of the primary ovarian cancer and onset of the metastatic brain lesion in these cases ranged from several months to 10 years.<sup><xref rid="B15" ref-type="bibr">15)</xref></sup> In our institution, the mean interval between diagnosis of the primary ovarian cancer and diagnosis of meta-static brain tumors was 1,271 days (3.5 years) (<xref ref-type="table" rid="T1">Table 1</xref>). As shown in <xref ref-type="table" rid="T1">Table 1</xref>, 6 (75%) of 8 cases of metastatic brain tumors arising from ovarian cancer in our institution had a single intracranial lesion. In contrast, all cases of calcified metastatic brain tumors arising from ovarian cancer in the literature had multiple lesions (<xref ref-type="table" rid="T2">Table 2</xref>), which favored the use of whole brain radiation therapy as the preferred therapeutic modality in those cases. Thus, the present case of a patient with a single calcified metastatic cerebellar tumor arising from ovarian cancer is extremely rare.</p><p>Due to simple statistics, increase in survival in response to advances in chemotherapy may actually result in an increase in the incidence at which subsequent brain metastases (due to cancer relapse) are diagnosed. Interestingly in the present case, the interval between the initial diagnosis of the brain lesion and treatment of the cerebellar tumor was 2 years, which suggests a relatively indolent tumor phenotype that is similar to that seen for meningioma. Therefore, calcification might be an indicator of a relatively long survival in the case of metastatic tumor, provided the primary cancer is controlled.</p><p>In conclusion, complete tumor resection may be an acceptable approach for patients with calcified metastatic tumors both for therapeutic considerations and to obtain tissue for confirmation of histopathological diagnosis. Metastatic brain tumors can be calcified, and not only ovarian cancer but also other cancers should be considered within the differential diagnosis of calcified intracranial lesions to avoid any delay in diagnosis or treatment.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ara Callizo</surname><given-names>JR</given-names></name><name><surname>Gimenez-Mas</surname><given-names>JA</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Lacasa</surname><given-names>J</given-names></name></person-group>: 
<article-title>Calcified brain metastases from acinar-cell carcinoma of pancreas</article-title>. 
<source>Neuroradiology</source>
<volume>31</volume>: 
<fpage>200</fpage>, 
<year>1989</year>
<pub-id pub-id-type="pmid">2747904</pub-id></mixed-citation></ref><ref id="B2"><label>2)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burt</surname><given-names>TB</given-names></name><name><surname>Yang</surname><given-names>PJ</given-names></name><name><surname>Gibby</surname><given-names>W</given-names></name></person-group>: 
<article-title>Calcified brain metastases from ovarian cancer</article-title>. 
<source>AJNR Am J Neuroradiol</source>
<volume>9</volume>: 
<fpage>613</fpage>, 
<year>1988</year>
<pub-id pub-id-type="pmid">3132844</pub-id></mixed-citation></ref><ref id="B3"><label>3)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Homma</surname><given-names>T</given-names></name><name><surname>Kohga</surname><given-names>H</given-names></name><name><surname>Uki</surname><given-names>J</given-names></name><name><surname>Shisa</surname><given-names>H</given-names></name></person-group>: 
<article-title>A lung cancer case with numerous calcified metastatic nodules of the brain</article-title>. 
<source>Neuroradiology</source>
<volume>30</volume>: 
<fpage>265</fpage>&#x02013;
<lpage>268</lpage>, 
<year>1988</year>
<pub-id pub-id-type="pmid">3405417</pub-id></mixed-citation></ref><ref id="B4"><label>4)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gaze</surname><given-names>MN</given-names></name><name><surname>Gregor</surname><given-names>A</given-names></name><name><surname>Whittle</surname><given-names>IR</given-names></name><name><surname>Sellar</surname><given-names>RJ</given-names></name></person-group>: 
<article-title>Calcified cerebral metastasis from cervical carcinoma</article-title>. 
<source>Neuroradiology</source>
<volume>31</volume>: 
<fpage>291</fpage>, 
<year>1989</year>
<pub-id pub-id-type="pmid">2779787</pub-id></mixed-citation></ref><ref id="B5"><label>5)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Halpin</surname><given-names>S</given-names></name><name><surname>Kingsley</surname><given-names>D</given-names></name></person-group>: 
<article-title>Disappearance of cerebral calcification as a sign of tumor growth</article-title>. 
<source>AJNR Am J Neuroradiol</source>
<volume>14</volume>: 
<fpage>119</fpage>&#x02013;
<lpage>122</lpage>, 
<year>1993</year>
<pub-id pub-id-type="pmid">8427072</pub-id></mixed-citation></ref><ref id="B6"><label>6)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henr&#x000ed;quez</surname><given-names>I</given-names></name><name><surname>Castro</surname><given-names>C</given-names></name><name><surname>Berenguer</surname><given-names>J</given-names></name><name><surname>Biete</surname><given-names>A</given-names></name></person-group>: 
<article-title>Calcification of presumed ovarian carcinoma brain metastases following radiotherapy</article-title>. 
<source>Br J Radiol</source>
<volume>72</volume>: 
<fpage>85</fpage>&#x02013;
<lpage>88</lpage>, 
<year>1999</year>
<pub-id pub-id-type="pmid">10341696</pub-id></mixed-citation></ref><ref id="B7"><label>7)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hwang</surname><given-names>TL</given-names></name><name><surname>Valdivieso</surname><given-names>JG</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name><name><surname>Wolin</surname><given-names>MJ</given-names></name></person-group>: 
<article-title>Calcified brain metastasis</article-title>. 
<source>Neurosurgery</source>
<volume>32</volume>: 
<fpage>451</fpage>&#x02013;
<lpage>454</lpage>; 
<comment>discussion 454</comment>, 
<year>1993</year>
<pub-id pub-id-type="pmid">8455771</pub-id></mixed-citation></ref><ref id="B8"><label>8)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakase</surname><given-names>H</given-names></name><name><surname>Sakaki</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Tsunoda</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Hiasa</surname><given-names>Y</given-names></name></person-group>: 
<article-title>Multiple calcified metastatic brain tumor&#x02014;case report</article-title>. 
<source>Neurol Med Chir (Tokyo)</source>
<volume>31</volume>: 
<fpage>787</fpage>&#x02013;
<lpage>791</lpage>, 
<year>1991</year>
<pub-id pub-id-type="pmid">1726228</pub-id></mixed-citation></ref><ref id="B9"><label>9)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neumann</surname><given-names>MA</given-names></name></person-group>: 
<article-title>Iron and calcium dysmetabolism in the brain with special predilection for globus pallidus and cerebellum</article-title>. 
<source>J Neuropathol Exp Neurol</source>
<volume>22</volume>: 
<fpage>148</fpage>&#x02013;
<lpage>163</lpage>, 
<year>1963</year>
<pub-id pub-id-type="pmid">13938167</pub-id></mixed-citation></ref><ref id="B10"><label>10)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohmoto</surname><given-names>Y</given-names></name><name><surname>Nishizaki</surname><given-names>T</given-names></name><name><surname>Kajiwara</surname><given-names>K</given-names></name><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Kameda</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name></person-group>: 
<article-title>Calcified metastatic brain tumor&#x02014;two case reports</article-title>. 
<source>Neurol Med Chir (Tokyo)</source>
<volume>42</volume>: 
<fpage>264</fpage>&#x02013;
<lpage>267</lpage>, 
<year>2002</year>
<pub-id pub-id-type="pmid">12116533</pub-id></mixed-citation></ref><ref id="B11"><label>11)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ricke</surname><given-names>J</given-names></name><name><surname>Baum</surname><given-names>K</given-names></name><name><surname>Hosten</surname><given-names>N</given-names></name></person-group>: 
<article-title>Calcified brain metastases from ovarian carcinoma</article-title>. 
<source>Neuroradiology</source>
<volume>38</volume>: 
<fpage>460</fpage>&#x02013;
<lpage>461</lpage>, 
<year>1996</year>
<pub-id pub-id-type="pmid">8837093</pub-id></mixed-citation></ref><ref id="B12"><label>12)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tashiro</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>A</given-names></name><name><surname>Aoyama</surname><given-names>I</given-names></name><name><surname>Nin</surname><given-names>K</given-names></name><name><surname>Shimotake</surname><given-names>K</given-names></name><name><surname>Tashiro</surname><given-names>H</given-names></name><name><surname>Nishioka</surname><given-names>T</given-names></name></person-group>: 
<article-title>Calcified metastatic brain tumor</article-title>. 
<source>Neurosurgery</source>
<volume>26</volume>: 
<fpage>1065</fpage>&#x02013;
<lpage>1070</lpage>, 
<year>1990</year>
<pub-id pub-id-type="pmid">2194141</pub-id></mixed-citation></ref><ref id="B13"><label>13)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tomita</surname><given-names>T</given-names></name><name><surname>Larsen</surname><given-names>MB</given-names></name></person-group>: 
<article-title>Calcified metastases to the brain in a child: case report</article-title>. 
<source>Neurosurgery</source>
<volume>13</volume>: 
<fpage>435</fpage>&#x02013;
<lpage>437</lpage>, 
<year>1983</year>
<pub-id pub-id-type="pmid">6633837</pub-id></mixed-citation></ref><ref id="B14"><label>14)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsutsumi</surname><given-names>M</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Kawaguchi</surname><given-names>T</given-names></name><name><surname>Kaneko</surname><given-names>Y</given-names></name><name><surname>Ooigawa</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group>: 
<article-title>Intracranial meningeal malignant fibrous histiocytoma mimicking parasagittal meningioma&#x02014;case report</article-title>. 
<source>Neurol Med Chir (Tokyo)</source>
<volume>41</volume>: 
<fpage>90</fpage>&#x02013;
<lpage>93</lpage>, 
<year>2001</year>
<pub-id pub-id-type="pmid">11255634</pub-id></mixed-citation></ref><ref id="B15"><label>15)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Umezu</surname><given-names>H</given-names></name><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Aiba</surname><given-names>T</given-names></name><name><surname>Unakami</surname><given-names>M</given-names></name></person-group>: 
<article-title>Calcified intracranial metastatic tumor mimicking meningioma&#x02014;case report</article-title>. 
<source>Neurol Med Chir (Tokyo)</source>
<volume>34</volume>: 
<fpage>108</fpage>&#x02013;
<lpage>110</lpage>, 
<year>1994</year>
<pub-id pub-id-type="pmid">7514757</pub-id></mixed-citation></ref><ref id="B16"><label>16)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamada</surname><given-names>I</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name></person-group>: 
<article-title>Calcification in cerebral non-Hodgkin's lymphoma: CT demonstration</article-title>. 
<source>Neuroradiology</source>
<volume>31</volume>: 
<fpage>372</fpage>, 
<year>1989</year>
<pub-id pub-id-type="pmid">2797437</pub-id></mixed-citation></ref><ref id="B17"><label>17)</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Harigaya</surname><given-names>Y</given-names></name><name><surname>Noguchi</surname><given-names>O</given-names></name><name><surname>Okamoto</surname><given-names>K</given-names></name><name><surname>Hirai</surname><given-names>S</given-names></name></person-group>: 
<article-title>Calcified miliary brain metastases with mitochondrial inclusion bodies</article-title>. 
<source>J Neurol Neurosurg Psychiatr</source>
<volume>56</volume>: 
<fpage>110</fpage>&#x02013;
<lpage>111</lpage>, 
<year>1993</year>
</mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Preoperative computed tomography (CT) scan showing calcified tumor in the right cerebellar hemisphere. A: A calcified tumor in the right cerebellar hemisphere was incidentally discovered 2 years before surgery. B: Follow-up CT 1 year later revealed slow growth of the tumor. C: The tumor grew progressively, compressing the brainstem. The ambient and quadrigeminal cisterns were not visualized, and the inferior horn of the lateral ventricle was enlarged.</p></caption><graphic xlink:href="nmc-53-722-g1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Preoperative magnetic resonance imaging (MRI) showing a lesion in the right cerebellar hemisphere that was isoin-tense on T<sub>1</sub>-weighted imaging (A) and that was hyperintense on T<sub>2</sub>-weighted imaging (B). The tumor was heterogeneously enhanced with gadolinium on axial (C) and sagittal images (D). Note the tonsillar herniation causing, compression of the brainstem and obstructive hydrocephalus.</p></caption><graphic xlink:href="nmc-53-722-g2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Photomicrograph revealing mucinous tumor cells with acinar formation and papillary proliferation. Tumor contained psammomatous bodies in the stroma with atypical and mitotic cells (hematoxylin and eosin: A, &#x000d7;40; B, &#x000d7;200).</p></caption><graphic xlink:href="nmc-53-722-g3"/></fig><fig id="F4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Postoperative computed tomography (CT) scan showing that the calcified tumor was totally removed.</p></caption><graphic xlink:href="nmc-53-722-g4"/></fig><fig id="F5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Postoperative T<sub>1</sub>-weighted (A) and T<sub>2</sub>-weighted (B) magnetic resonance (MR) imaging, and MR image with gadolinium in the axial (C) and sagittal (D) planes, showing that the tumor was completely removed. Note that the brainstem was decompressed and that hydrocephalus had improved.</p></caption><graphic xlink:href="nmc-53-722-g5"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of metastatic brain tumors arising from primary ovarian cancers in patients seen at our institution</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" rowspan="1" colspan="1">Stage for ovarian cancer</th><th align="center" valign="middle" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" rowspan="1" colspan="1">No. of brain metastasis</th><th align="center" valign="middle" rowspan="1" colspan="1">Treatment for brain metastasis</th><th align="center" valign="middle" rowspan="1" colspan="1">Chemotherapy</th><th align="center" valign="middle" rowspan="1" colspan="1">Interval between diagnosis of ovary cancer and brain metastasis</th><th align="center" valign="middle" rowspan="1" colspan="1">Overall survival after treatment of brain metastasis</th><th align="center" valign="middle" rowspan="1" colspan="1">RPA</th><th align="center" valign="middle" rowspan="1" colspan="1">GPA</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">66</td><td align="center" valign="top" rowspan="1" colspan="1">IV</td><td align="center" valign="top" rowspan="1" colspan="1">Temporal</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">Subtotal removal &#x00026; WBRT</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">24.5 months</td><td align="left" valign="top" rowspan="1" colspan="1">23.9 months</td><td align="center" valign="top" rowspan="1" colspan="1">I</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">IV</td><td align="center" valign="top" rowspan="1" colspan="1">Brain stem</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">10.1 months</td><td align="left" valign="top" rowspan="1" colspan="1">10 days</td><td align="center" valign="top" rowspan="1" colspan="1">III</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">IV</td><td align="center" valign="top" rowspan="1" colspan="1">Frontal</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">GKS</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">79.1 months</td><td align="left" valign="top" rowspan="1" colspan="1">alive</td><td align="center" valign="top" rowspan="1" colspan="1">I</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">57</td><td align="center" valign="top" rowspan="1" colspan="1">IIIc</td><td align="center" valign="top" rowspan="1" colspan="1">Occipital</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">Total removal &#x00026; GKS</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">25.7 months</td><td align="left" valign="top" rowspan="1" colspan="1">36.4 months</td><td align="center" valign="top" rowspan="1" colspan="1">I</td><td align="center" valign="top" rowspan="1" colspan="1">3.5</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">53</td><td align="center" valign="top" rowspan="1" colspan="1">IIIc</td><td align="center" valign="top" rowspan="1" colspan="1">Temporal</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">GKS</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">26.6 months</td><td align="left" valign="top" rowspan="1" colspan="1">2.6 months</td><td align="center" valign="top" rowspan="1" colspan="1">III</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">IIIc</td><td align="center" valign="top" rowspan="1" colspan="1">Frontal</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">Subtotal removal &#x00026; GKS</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">41.5 months</td><td align="left" valign="top" rowspan="1" colspan="1">alive</td><td align="center" valign="top" rowspan="1" colspan="1">I</td><td align="center" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">60</td><td align="center" valign="top" rowspan="1" colspan="1">IIIc</td><td align="center" valign="top" rowspan="1" colspan="1">Cerebellar</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">Total removal &#x00026; GKS</td><td align="left" valign="top" rowspan="1" colspan="1">taxol/CBDCA</td><td align="left" valign="top" rowspan="1" colspan="1">38.1 months</td><td align="left" valign="top" rowspan="1" colspan="1">15.5 months</td><td align="center" valign="top" rowspan="1" colspan="1">I</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><italic>33</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>IIIc</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Cerebellar</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>1</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>Total removal &#x00026; WBRT</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>GEM</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>114.5 months</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>alive</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>II</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>3</italic></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p><italic>Italics</italic> indicate the present case. CBDCA: carboplatin, GEM: gemcitabine, GKS: gamma knife surgery, GPA: graded prognosis assessment, RPA: recursive partitioning analysis, WBRT: whole brain radiation therapy.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>List of calcified metastatic brain tumors arising from primary ovarian cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Author (year)</th><th align="center" valign="middle" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" rowspan="1" colspan="1">Stage for ovarian cancer</th><th align="center" valign="middle" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" rowspan="1" colspan="1">Single/multiple lesions</th><th align="center" valign="middle" rowspan="1" colspan="1">Chemotherapy</th><th align="center" valign="middle" rowspan="1" colspan="1">Interval between diagnosis of ovary cancer and brain metastasis</th><th align="center" valign="middle" rowspan="1" colspan="1">Treatment for brian metastasis</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Burt TB et al. (1988)<sup><xref rid="B2" ref-type="bibr">2)</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">65</td><td align="center" valign="top" rowspan="1" colspan="1">III</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebellar</td><td align="left" valign="top" rowspan="1" colspan="1">Multiple</td><td align="left" valign="top" rowspan="1" colspan="1">n.d.</td><td align="left" valign="top" rowspan="1" colspan="1">3 months</td><td align="left" valign="top" rowspan="1" colspan="1">n.d.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Burt TB et al. (1988)<sup><xref rid="B2" ref-type="bibr">2)</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">IIIc</td><td align="left" valign="top" rowspan="1" colspan="1">Cerebellar, medulla</td><td align="left" valign="top" rowspan="1" colspan="1">Multiple</td><td align="left" valign="top" rowspan="1" colspan="1">n.d.</td><td align="left" valign="top" rowspan="1" colspan="1">n.d.</td><td align="left" valign="top" rowspan="1" colspan="1">Biopsy</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Henriquez et al. (1999)<sup><xref rid="B6" ref-type="bibr">6)</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">IIIc</td><td align="left" valign="top" rowspan="1" colspan="1">Frontal, parietal</td><td align="left" valign="top" rowspan="1" colspan="1">Multiple</td><td align="left" valign="top" rowspan="1" colspan="1">CBDCA/CPA</td><td align="left" valign="top" rowspan="1" colspan="1">1 year</td><td align="left" valign="top" rowspan="1" colspan="1">WBRT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ricke J et al. (1996)<sup><xref rid="B11" ref-type="bibr">11)</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">IV</td><td align="left" valign="top" rowspan="1" colspan="1">Frontal</td><td align="left" valign="top" rowspan="1" colspan="1">Multiple</td><td align="left" valign="top" rowspan="1" colspan="1">n.d.</td><td align="left" valign="top" rowspan="1" colspan="1">5 months</td><td align="left" valign="top" rowspan="1" colspan="1">Biopsy</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Present case</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>33</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>IIIc</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Cerebellar</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Single</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>GEM</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>10 years</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Total removal &#x00026; WBRT</italic></td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p><italic>Italics</italic> indicate the present case. CBDCA: carboplatin, CPA: cyclophosphamide, GEM: gemcitabine, n.d.: not described, WBRT: whole brain radiation therapy.</p></fn></table-wrap-foot></table-wrap></floats-group></article>